Hemarina announces a fundraising of more than 8M€
Hemarina, the marine Biotechnology company centered on the development of innovative oxygen carriers, announces a fundraising of more than 8M€.... View Article
The Atlanpole Biotherapies cluster’s confirmed excellence in immunotherapy
The cluster’s success The cluster’s laboratories in fundamental and clinical research in immunotherapy and the companies are excelling in this... View Article
Atlab Pharma & Telix Pharmaceuticals: agreement for prostate cancer
From Australia to France Atlab Pharma (Nantes, FRANCE) and Telix Pharmaceuticals (Melbourne, AUSTRALIA) conclude a Therapeutic Product Development Agreement for Prostate... View Article
OSE Immunotherapeutics: at BIO CEO & Investor Conference, NY, Feb. 13&14, 2017
OSE Immunotherapeutics announced that its management team will present an overview of the Company’s business and will be available to participate in one-on-one meetings with... View Article
InFlectis BioScience: partnership in ophthalmology
InFlectis BioScience & Laboratoire de Génétique Médicale de Strasbourg enter into a strategic partnership in ophthalmology InFlectis BioScience announced... View Article
Hemarina: winner of Creative Next contest
New York, NY, February 9, 2016 — Business France, the French national agency supporting the international development of the French economy,... View Article
ASTATE: SUBJECT OF A CLINICAL STUDY IN NANTES UNIVERSITY HOSPITAL
Astate, so rare and so precious in the treatment of cancer. “It is mysterious, only exists in minute quantities,... View Article
VALNEVA RECEIVES THE FRENCH “SOCIÉTÉ COTÉE” PRIZE OF THE DELOITTE FAST 50 CONTEST
Valneva SE, a biotechnology company, which is marketing and developing innovative vaccines, announced that they have received the “Société Côtée”... View Article
OSE IMMUNOTHERAPEUTICS: 1ST PRIZE OF DELOITTE IN EXTENSO TECHNOLOGY FAST 50
OSE Immunotherapeutics, a biotechnology company, which is a member of the Atlanpole Biotherapies cluster and which develops immunotherapy for activation... View Article
CESTI IHU: TOWARDS NEW CELLULAR THERAPY APPROACHES IN TRANSPLANTATION
About characterizing regulatory populations to develop cell therapy approaches in transplantation. “The CESTI IHU has made it possible to strengthen... View Article